Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)
Launched by NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST · Mar 20, 2018
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
1. What is the problem being addressed? Greater trochanteric pain syndrome (GTPS), also known as trochanteric bursitis, is a painful condition characterised by pain around the greater trochanter usually affecting middle aged women (1). It was first described, as trochanteric bursitis in 1958 (2). Further details on the clinical symptoms published in 1978 as pain over the greater trochanter on walking, squatting or climbing stairs and pain on lying on the affected side or when crossing one's legs (3). Little described tenderness over the greater trochanter over the insertion of the gluteus t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Over 18 years of age
- • 2. Symptoms consistent with GTPS present for at least 6 months
- • 3. Radiological diagnosis of GTPS using MRI, or ultrasound scan if MRI contraindicated
- • 4. Failed conservative management in any other care setting
- • 5. Patient is willing and able to provide written informed consent.
- Exclusion Criteria:
- • 1. Lacks capacity to provide consent
- • 2. Has hip joint osteoarthritis requiring treatment on a plain radiograph
- • 3. Presence of confounding pathologies of the hip MRI
- • 4. Any extensive surgery or deformity of the hip on X-ray.
- • 5. Presence of systemic disorders -coagulopathy, active infection, immune system disorders, peripheral neuropathy, malignancy, unresolved fractures.
- • 6. Had any surgical treatment specifically targeted at GTPS e.g. bursectomy/Ilio-tibial band lengthening
- • 7. Pregnancy
- • 8. Anti-coagulant therapy eg warfarin, rivaroxaban, apixaban, dabigatran
- • 9. Haemaglobin \<10g/dL or platelets \< 150,000/ul
- • 10. Unable to safely stop anti-platelet/NSAID medications eg. Recent cardiac stenting
- • 11. Has lumbar-sacral spine pathology or a recent history of acute hip trauma
- • 12. Has a recent history of acute sciatica
- • 13. Is not able to attend or comply with treatment or follow-up scheduling
- • 14. Participates in any other clinical trial
About Northumbria Healthcare Nhs Foundation Trust
Northumbria Healthcare NHS Foundation Trust is a leading healthcare provider in the North East of England, renowned for its commitment to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust actively engages in innovative research initiatives aimed at improving health outcomes and enhancing treatment options across a range of medical disciplines. With a robust framework for clinical governance and a multidisciplinary team of experienced professionals, Northumbria Healthcare focuses on fostering collaborative partnerships to drive evidence-based practices and contribute to the broader scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newcastle Upon Tyne, Tyne And Wear, United Kingdom
Patients applied
Trial Officials
Ajay Malviya
Principal Investigator
Northumbria Healthcare NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials